Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Microbot Medical Inc (NASDAQ: MBOT) was $1.59 for the day, down -7.02% from the previous closing price of $1.71. In other words, the price has decreased by -$7.02 from its previous closing price. On the day, 1.69 million shares were traded.
Ratios:
Our analysis of MBOT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.64. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 13, 2020, Reiterated its Buy rating but revised its target price to $26 from $12 previously.
On December 24, 2019, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $10 to $12.
On January 31, 2018, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $1.75.Ladenburg Thalmann initiated its Buy rating on January 31, 2018, with a $1.75 target price.
Stock Price History:
Over the past 52 weeks, MBOT has reached a high of $3.38, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is -4.24%, while the 200-Day Moving Average is calculated to be 37.79%.
Shares Statistics:
A total of 34.74M shares are outstanding, with a floating share count of 30.96M. Insiders hold about 10.88% of the company’s shares, while institutions hold 7.08% stake in the company.
